Cargando...
Evaluation of the Biodistribution of Serinolamide-Derivatized C(60) Fullerene
Carbon nanoparticles have consistently been of great interest in medicine. However, there are currently no clinical materials based on carbon nanoparticles, due to inconsistent biodistribution and excretion data. In this work, we have synthesized a novel C(60) derivative with a metal chelating agent...
Guardado en:
| Publicado en: | Nanomaterials (Basel) |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7023239/ https://ncbi.nlm.nih.gov/pubmed/31941058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nano10010143 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|